Given the established role of ferroptosis in β-cell dysfunction and the limited understanding of PMS’s therapeutic mechanisms in T2DM, this study aims to explore whether PMS can ameliorate T2DM by modulating the XCT/GPX4 pathway to inhibit ferroptosis in pancreatic β-cells. This evidence concerns the gene GPX4 and type 2 diabetes mellitus.